AzTrials
AzTrials

Central Nervous System SensitizationNCT03058003

Correlation Between Central Sensitization Inventory and Posturographic Data

An observational study of Central Nervous System Sensitization, run by Caps Research Network at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate the use of balance as a screening tool for Central Sensitization, a condition of the nervous system that is associated with the development and maintenance of chronic pain. This is done by comparing the scores of a gold standard screening tool (the Central Sensitization Inventory) with balance data. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Central Nervous System Sensitization
What is being tested?
Posturography Evaluation and Central Sensitization Inventory
How many people
180 participants
Where
2 sitesin 2 countries
Study dates
May 2016to Apr 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adults, self assess to be in good health or diagnosed with Central Nervous System Sensitization

Who may be able to join

  • Adults, self assessed to be in good health, or medically diagnosed with any of the following pathologies: Chronic nonspecific low back pain (CNSLBP), Fibromyalgia (FM), Cervicogenic Headche (CH), Chronic Tension Type Headache (CTT), Irritable Bowel Syndrome (IBS), Whiplash Associated Disorder (WAD), Temporomandibular Disorder (TMD)

Who cannot join

  • Pregnant women will be excluded, as will be minors

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

United States1 site
  • Innova Brain Rehabilitation

    Marietta, Georgia, 30062

Other trials in United States

Australia1 site
  • Small Street Clinic

    Hampton, Victoria, 3188

Other trials in Australia

About this study

To investigate the use of balance as a screening tool for Central Sensitization, a condition of the nervous system that is associated with the development and maintenance of chronic pain. This is done by comparing the scores of a gold standard screening tool (the Central Sensitization Inventory) with balance data.

Read the detailed description

First, subjects will be asked to answer a brief medical questionnaire pertaining their general health status: since some of the subjects will be self-assessed to be "healthy" (no medical examination will be conducted to determine if this is indeed the case), the questionnaire will be used to determine if there are any possible known causes of poor balance performance. The questionnaire will not constitute an inclusion/exclusion criterion, it just has a classification purpose.

Subjects will then be asked to fill in the Central Sensitization Inventory (CSI), scoring each of the 25 items on a scale from 0 (never) to 4 (always).

Then, subjects will stand for 2 minutes on a compliant surface (a 4" tall foam cushion of known mechanical properties) to "learn" how to stand on it. Afterward, they will undergo posturography testing using the extended modified Clinical Testing of Sensory Integration in Balance (ext_mCTSIB) protocol: the subjects will be required to stand on a hard or compliant surface in a comfortable posture, feet shoulder width, with eyes open or closed, arms to the side and free to move, gazing forward, and breathing normally, with head straight, turned right or left, flexed or extended.

Being tested
Posturography Evaluation, Central Sensitization Inventory
Keywords
balance, postural, postural equilibrium, chronic pain, Chronic nonspecific low back pain, Fibromyalgia, Cervicogenic headache, Chronic tension type headache, Irritable bowel syndrome, Whiplash associated disorder, Temporomandibular disorder
Medical subject headings
Chronic Pain, Fibromyalgia, Post-Traumatic Headache, Irritable Bowel Syndrome, Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Posturography EvaluationDiagnostic test

    Also called Balance Testing, CAPS® Testing

    Posturography testing using the extended modified Clinical Testing of Sensory Integration in Balance (ext_mCTSIB) protocol: the subjects will be required to stand on a hard or compliant surface in a comfortable posture, feet shoulder width, with eyes open or closed, arms to the side and free to move, gazing forward, and breathing normally, with head straight, turned right or left, flexed or extended

  • Central Sensitization InventoryOther

    Standard chronic pain questionnaire: the subjects will be required to score each of the 25 items on a scale from 0 (never) to 4 (always)

Study groups in NCT03058003
Study groupRoleWhat they receive
Patientssubjects suffering from chronic pain undergoing Posturography Evaluation and Central Sensitization Inventory
Receives: Diagnostic Test: Posturography Evaluation; Other: Central Sensitization Inventory
Healthysubjects self assessed to be in good health undergoing Posturography Evaluation and Central Sensitization Inventory
Receives: Diagnostic Test: Posturography Evaluation; Other: Central Sensitization Inventory

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stability Score

    The Stability Score (calculated as percentage ratio of the actual sway and the theoretical limit of stability) will be used to investigate if there is any difference between healthy controls and subjects affected by chronic pain. Statistical tools such t-tests and correlation coefficients will be used for assess if there is a difference between the two groups

    Measured: immediately after data collection

  2. CSI

    The sum of all the answers to the Central Sensitization Inventory will be used to investigate if there is any difference between healthy controls and subjects affected by chronic pain. Statistical tools such t-tests and correlation coefficients will be used for assess if there is a difference between the two groups

    Measured: immediately after data collection

Secondary outcomes (1)
  1. CSI-SS

    Correlation between the Stability Score and the CSI result for each individual to determine if balance is an indicator of Central Nervous System Sensitization

    Measured: immediately after data collection

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2017
  2. Study startMay 2016
  3. Primary completionJan 2018
  4. Study completionApr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03058003
Sponsor's protocol ID
CI-IRB-20170124001
Status last verified
Aug 2021
First submitted
16 Feb 2017
Last updated
23 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Central Nervous System Sensitization, run by Caps Research Network at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stability Score (time frame: immediately after data collection). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in